Page 2

  • CMS Administrator Dr. Mehmet Oz speaks at an Aspen Institute event.
    Image attribution tooltip
    Permission granted by Aspen Institute
    Image attribution tooltip

    CMS finalizes competitive bidding changes to diabetes devices

    AdvaMed supported adjustments made from a draft version but still has concerns about the impact on patient access.

  • J&J HQ
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J’s US orthopedic leader leaves amid DePuy spinout process

    Leslie Storms started a new role on Monday as president of Ethos Veterinary Health.

  • Boston Scientific's Farawave pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    CMS covers cardiac ablation in ambulatory surgery centers

    Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.

  • A person wearing a white, round patch on their upper arm holds a phone.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    OIG report finds Medicare overpaying for CGMs and supplies

    The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five years, the government watchdog said.

  • The facade of the U.S. Capitol building is seen along with trees and a reflection pond
    Image attribution tooltip
    Kara Arundel/MedTech Dive
    Image attribution tooltip

    Lawmakers propose Medicare reimbursement pathway for AI devices

    AdvaMed supports the legislation, which is intended to ensure AI-enabled devices receive an accurate CMS payment code.

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic taps Jim Peichel as CTO

    Peichel, who has worked at Medtronic for more than 25 years, succeeds Ken Washington, who retired earlier this month.

  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott issues correction for millions of glucose sensors

    The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.

  • Professional photo of Ashley McEvoy
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet unveils plans for new diabetes devices

    The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 diabetes in 2028.

  • FDA sign
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Ceribell wins FDA clearance for seizure-detection algorithm in neonates

    By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 million market.

  • A 3D visualization of red blood cells traveling through a blood vessel.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Okami raises $45M to commercialize vascular embolization devices

    The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

  • Senior Research Associate Tanya Quint loads one of the instruments used to run Exact Sciences' Cologuard test at the company's headquarters in Madison, Wis. (Photo: Business Wire)
    Image attribution tooltip
    Courtesy of Business Wire/Exact Sciences
    Image attribution tooltip

    Abbott’s $21B Exact Sciences buy reveals future strategy

    The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing. 

    M&A
  • A person stands in front of the screen of a machine on wheels, near a sign that says "GE HealthCare"
    Image attribution tooltip
    Stringer via Getty Images
    Image attribution tooltip

    GE HealthCare to buy Intelerad for $2.3B

    GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal expands GE HealthCare’s presence in more outpatient settings.

    M&A
  • A birds-eye picture of a stethoscope and piggy bank against a blue background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Health tech venture capital investment rebounds in 2025: report

    Funding through the third quarter surpassed last year’s total, according to PitchBook. Meanwhile, average deal sizes are skyrocketing as high valuations — especially for AI startups — drive larger rounds.

  • M&A due diligence lawyers legal
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Solventum inks $725M Acera takeover

    The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.

  • Nick West, chief medical officer of J&J unit Shockwave, smiles in a headshot.
    Image attribution tooltip
    Permission granted by J&J MedTech
    Image attribution tooltip
    Q&A

    Shockwave’s Nick West on shaking up treatment for blocked arteries

    The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.

  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott to acquire Exact Sciences for about $21B

    The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.

    Updated Nov. 20, 2025
  • A sign spelling Roche hangs on the side of a building.
    Image attribution tooltip
    Sedat Suna via Getty Images
    Image attribution tooltip

    Roche inks deal for rights to Freenome cancer tests outside US

    Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits, similar to with their prior success in IVD kits.”

  • The U.S. Capitol stands in the distance as morning traffic moves along North Capitol Street Northwest on October 01, 2025 in Washington, DC. The government shut down early Wednesday after Congress failed to reach a funding deal.
    Image attribution tooltip
    Chip Somodevilla / Staff via Getty Images
    Image attribution tooltip

    Republican antipathy during key Senate hearing darkens outlook for ACA subsidy extension

    More generous subsidies for Affordable Care Act plans have helped millions of Americans afford insurance. Chances are becoming slimmer that the assistance will survive the year.

  • A physician in blue scrubs and a mask looks at Philips' DeviceGuide images on a large screen.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips, Edwards team on AI-based guide for mitral valve repair

    Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device during transcatheter heart procedures.